Cargando…

Relationship between medical history and multiple sclerosis: A-case-control study

This project sought to explore the potential association between medical history and the development of multiple sclerosis (MS) by conducting a retrospective study. This population-based case-control study included 200 MS cases and 2 control groups of 200 patients and healthy individuals each. Data...

Descripción completa

Detalles Bibliográficos
Autores principales: esfandiari, Fatemeh, Ghazaiean, Mobin, Darvishi-Khezri, Hadi, Baghbanian, Seyed Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256330/
https://www.ncbi.nlm.nih.gov/pubmed/37335649
http://dx.doi.org/10.1097/MD.0000000000033906
_version_ 1785057080771608576
author esfandiari, Fatemeh
Ghazaiean, Mobin
Darvishi-Khezri, Hadi
Baghbanian, Seyed Mohammad
author_facet esfandiari, Fatemeh
Ghazaiean, Mobin
Darvishi-Khezri, Hadi
Baghbanian, Seyed Mohammad
author_sort esfandiari, Fatemeh
collection PubMed
description This project sought to explore the potential association between medical history and the development of multiple sclerosis (MS) by conducting a retrospective study. This population-based case-control study included 200 MS cases and 2 control groups of 200 patients and healthy individuals each. Data was collected through face-to-face interviews, medical file reviews, and an electronic checklist. Multivariable analysis was used to calculate odds ratios and 95% confidence intervals to estimate the risk of each medical history on MS occurrences. Of 600 participants, 381 (63.5%) individuals were female. The mean age of the participants was 36.5 ± 11.9 years. The adjusted risks of MS were 4.40; 95% CI: 1.73 to 11.1 for measles and 4.75; 95% CI: 2.05 to 11 for amoxicillin consumption. The adjusted MS odds for autoimmune disease including 4.63; 95% CI: 0.35 to 60.6 for psoriasis and 7.15; 95% CI: 1.87 to 27.2 for myasthenia gravis. On the other hand, the calculated adjusted odds of MS occurrence were 0.14; 95% CI: 0.03 to 0.69 for seizure and 0.17; 95% CI: 0.02 to 1.49 for epilepsy. This study suggested that individuals with autoimmune diseases should be monitored more closely, as they may be at an increased risk of developing other autoimmune conditions, particularly MS.
format Online
Article
Text
id pubmed-10256330
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102563302023-06-10 Relationship between medical history and multiple sclerosis: A-case-control study esfandiari, Fatemeh Ghazaiean, Mobin Darvishi-Khezri, Hadi Baghbanian, Seyed Mohammad Medicine (Baltimore) 5300 This project sought to explore the potential association between medical history and the development of multiple sclerosis (MS) by conducting a retrospective study. This population-based case-control study included 200 MS cases and 2 control groups of 200 patients and healthy individuals each. Data was collected through face-to-face interviews, medical file reviews, and an electronic checklist. Multivariable analysis was used to calculate odds ratios and 95% confidence intervals to estimate the risk of each medical history on MS occurrences. Of 600 participants, 381 (63.5%) individuals were female. The mean age of the participants was 36.5 ± 11.9 years. The adjusted risks of MS were 4.40; 95% CI: 1.73 to 11.1 for measles and 4.75; 95% CI: 2.05 to 11 for amoxicillin consumption. The adjusted MS odds for autoimmune disease including 4.63; 95% CI: 0.35 to 60.6 for psoriasis and 7.15; 95% CI: 1.87 to 27.2 for myasthenia gravis. On the other hand, the calculated adjusted odds of MS occurrence were 0.14; 95% CI: 0.03 to 0.69 for seizure and 0.17; 95% CI: 0.02 to 1.49 for epilepsy. This study suggested that individuals with autoimmune diseases should be monitored more closely, as they may be at an increased risk of developing other autoimmune conditions, particularly MS. Lippincott Williams & Wilkins 2023-06-09 /pmc/articles/PMC10256330/ /pubmed/37335649 http://dx.doi.org/10.1097/MD.0000000000033906 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle 5300
esfandiari, Fatemeh
Ghazaiean, Mobin
Darvishi-Khezri, Hadi
Baghbanian, Seyed Mohammad
Relationship between medical history and multiple sclerosis: A-case-control study
title Relationship between medical history and multiple sclerosis: A-case-control study
title_full Relationship between medical history and multiple sclerosis: A-case-control study
title_fullStr Relationship between medical history and multiple sclerosis: A-case-control study
title_full_unstemmed Relationship between medical history and multiple sclerosis: A-case-control study
title_short Relationship between medical history and multiple sclerosis: A-case-control study
title_sort relationship between medical history and multiple sclerosis: a-case-control study
topic 5300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256330/
https://www.ncbi.nlm.nih.gov/pubmed/37335649
http://dx.doi.org/10.1097/MD.0000000000033906
work_keys_str_mv AT esfandiarifatemeh relationshipbetweenmedicalhistoryandmultiplesclerosisacasecontrolstudy
AT ghazaieanmobin relationshipbetweenmedicalhistoryandmultiplesclerosisacasecontrolstudy
AT darvishikhezrihadi relationshipbetweenmedicalhistoryandmultiplesclerosisacasecontrolstudy
AT baghbanianseyedmohammad relationshipbetweenmedicalhistoryandmultiplesclerosisacasecontrolstudy